Cardiovascular Risk in Patients with Psoriatic Arthritis

Table 2

Studies on subclinical atherosclerosis in psoriatic arthritis.

	Year	Country	No. of patients	No. of controls	Male, no.	Age, mean ± SD	IMT, mm, PsA	IMT, mm, controls	𝑃 value	Carotid plagues, no. (%), PsA	Carotid plagues, no. (%), controls	Carotid plagues, 𝑃 value
Gonzalez-Juanatey et al. [33]	2007	Spain	59	59	31	48.8±12.4	0.699±0.165	0.643±0.111	0.031	9 (15)	3 (5)	0.068
Kimhi et al. [34]	2007	Israel	47	100	24	50±13.5	Average IMT: 0.76±0.11; adjusted IMT*: 0.726±0.075	Average IMT: 0.64±0.27; adjusted IMT*: 0.689±0.077;	Average IMT: <0.0001; adjusted IMT*: 0.04	—	—	—
Eder et al. [47]	2008	Israel	40	40	12	57.85 (43–76)^†	1.04±0.35	0.88±0.28	0.03	28 (70)	16 (40)	<0.05
Tam et al. [32]	2008	Hong Kong	82	82	42	49±10	Average IMT: 0.74±0.126; maximum IMT: 0.888±0.178	Average IMT: 0.626±0.074; maximum IMT: 0.722±0.106	Average IMT: <0.001; maximum IMT: <0.001	15 (18)	0	<0.001
Mazlan et al. [46]	2009	Malaysia	63	—	28	49.92 (13–74)^†	0.725±0.260	—	—	—	—	—
Atzeni et al. [31]	2011	Italy	22	35	12	54.9±12.97	0.64±0.26	0.62±0.52	NS	—	—	—

IMT: intima-media thickness; PsA: psoriatic arthritis; NS: not significant.
*Adjusted for age, hyperlipidemia, diabetes, and body mass index.
^†Mean (range).